World supplier of antibodies, antigens and kits since 2007
Other Products

PROTAK™ E3 ligase Ligand-Linker Conjugates 10

E31P32902-2DatasheetCOAMSDS
$3220/ 500mg
Specification
Quantity
Total: $3220

Ship worldwide. Contact order@enogene.com for ordering and bulk pricing or contact your local distributor.

Product Information

CAS No.1835705-57-1
Purity>98.00%
FormulaC32H47ClN4O6S
M.W.651.26
SolubilityDMSO : ≥ 50 mg/mL (76.77 mM)
Storage/StabilityStore at -20°C
BackgroundE3 ligase Ligand-Linker Conjugates 10 is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology.
E3 ligase Ligand-Linker Conjugates 10 uses the VHL ligand[1]. The linker is 6-2-2. The linkers contain a mixture of hydrophobic and hydrophilic moieties to balance the hydrophobicity/hydrophilicity of the resulting hybrid compounds. PROTACs that induce the degradation of an oncogenic tyrosine kinase, BCR-ABL has been developed. E3 ligase Ligand-Linker Conjugates 10 can be attached to potent TKIs (bosutinib and dasatinib) that mediate the degradation of c-ABL and BCR-ABL by hijacking either CRBN or VHL E3 ubiquitin ligase . US 20170121321 A1 [2]. Lai AC, et al. Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL. Angew Chem Int Ed Engl. 2016 Jan 11;55(2):807-10.
Price3220$
PROTAK™ E3 ligase Ligand-Linker Conjugates 10 | EnoGene Biotech Co. Ltd